Posted on May 29, 20265/29/26
The Indispensable Edge: Why the EVERSANA AI Agency Platform is a Must-Have for Expert Oncology Marketers
Posted on May 21, 20265/21/26
The Shattered Glass: Why the Future of Oncology Patient Support is an Agentic Ecosystem, Not a Portal
Posted on April 28, 20264/28/26
You Can Build AI In House.
But Should You?
Posted on April 23, 20264/23/26
From Experimentation to Ownership: Why the Future Belongs to Companies That Own AI
Posted on April 13, 20264/13/26
Build the Launch, Then Cut the Deal: A Smarter Playbook for Emerging Biotech Value
Posted on March 2, 20263/2/26
Navigating the Intersection of AI, Global Commercialization and Patient Value
Posted on January 27, 20261/27/26
Insights from Frontiers Health 2025: The Future of Commercialization Models
Posted on January 27, 20261/27/26
Insights from Frontiers Health 2025: How European Biotechs Can Navigate the U.S. Market
Posted on January 20, 20261/20/26
“Nothing changes if nothing changes.”
Posted on January 8, 20261/8/26